Cargando…

Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer

Pemetrexed (PEM) improves the overall survival of patients with advanced non-small cell lung cancer (NSCLC) when administered as maintenance therapy. However, PEM resistance often appears during the therapy. Although thymidylate synthase is known to be responsible for PEM resistance, no other mechan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanino, Ryosuke, Tsubata, Yukari, Harashima, Nanae, Harada, Mamoru, Isobe, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908287/ https://www.ncbi.nlm.nih.gov/pubmed/29682186 http://dx.doi.org/10.18632/oncotarget.24704

Ejemplares similares

Pemetrexed sensitizes human lung cancer cells to cytotoxic immune cells
por: Okimoto, Tamio, et al.
Publicado: (2020)

Current Therapeutic Strategies and Prospects for EGFR Mutation-Positive Lung Cancer Based on the Mechanisms Underlying Drug Resistance
por: Tsubata, Yukari, et al.
Publicado: (2021)

Picropodophyllin inhibits the growth of pemetrexed-resistant malignant pleural mesothelioma via microtubule inhibition and IGF-1R-, caspase-independent pathways
por: Sun, Rong, et al.
Publicado: (2022)

Protein tyrosine kinase 2: a novel therapeutic target to overcome acquired EGFR-TKI resistance in non-small cell lung cancer
por: Tong, Xuexia, et al.
Publicado: (2019)

Antibiotic‐induced reduction of abnormal lung shadow in pulmonary nodular lymphoid hyperplasia
por: Tanino, Akari, et al.
Publicado: (2020)

A Novel Model-Based Questionnaire Based on Low-Dose CT Screening Data for Chronic Obstructive Pulmonary Disease Diagnosis in Shimane, Japan
por: Tanino, Akari, et al.
Publicado: (2021)

Evaluation of the heterogeneous tissue distribution of erlotinib in lung cancer using matrix-assisted laser desorption ionization mass spectrometry imaging
por: Tsubata, Yukari, et al.
Publicado: (2017)

Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL
por: Hari, Yoko, et al.
Publicado: (2015)

Comparison of Ultra-Magnifying Endocytoscopic and Hematoxylin-Eosin-Stained Images of Lung Specimens
por: Kobayashi, Misato, et al.
Publicado: (2023)

High serum C-reactive protein levels predict survival in patients with treated advanced lung adenocarcinoma
por: Hotta, Takamasa, et al.
Publicado: (2021)

Usefulness of endocytoscopy in evaluating transbronchial biopsy specimens
por: Okuno, Takae, et al.
Publicado: (2022)

Comparative postoperative outcomes of GGN-dominant vs single lesion lung adenocarcinomas
por: Hotta, Takamasa, et al.
Publicado: (2020)

Characterization of a spontaneous mouse model of mild, accelerated aging via ECM degradation in emphysematous lungs
por: Tanino, Ryosuke, et al.
Publicado: (2023)

Drug-Induced Eosinophilic Pneumonia as an Adverse Event of Abemaciclib
por: Mitarai, Yuki, et al.
Publicado: (2022)

Use of saline to evaluate a cavity due to Mycobacterium kansasii infection during ultrathin bronchoscopy and endobronchial ultrasonography
por: Hamaguchi, Megumi, et al.
Publicado: (2021)

The Association Between Cyclooxygenase-2 –1195G/A (rs689466) Gene Polymorphism and the Clinicopathology of Lung Cancer in the Japanese Population: A Case-Controlled Study
por: Sun , Rong, et al.
Publicado: (2022)

Transfection of poly(I:C) can induce reactive oxygen species-triggered apoptosis and interferon-β-mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system
por: Harashima, Nanae, et al.
Publicado: (2014)

HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression
por: Harashima, Nanae, et al.
Publicado: (2017)

Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor‐mutant non‐small cell lung cancer: A prospective, multicenter, dose‐modification study
por: Tsubata, Yukari, et al.
Publicado: (2021)

Acute Interstitial Lung Disease Induced by Rechallenge with Ceritinib
por: Hotta, Takamasa, et al.
Publicado: (2019)

Deep learning-based diagnosis from endobronchial ultrasonography images of pulmonary lesions
por: Hotta, Takamasa, et al.
Publicado: (2022)

Therapeutic bronchoscopy in a lung abscess secondary to broncholithiasis
por: Amano, Yoshihiro, et al.
Publicado: (2019)

The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells
por: Zhang, Min, et al.
Publicado: (2015)

Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing state
por: Tongu, Miki, et al.
Publicado: (2015)

Reproducible abscopal effect in a patient with lung cancer who underwent whole‐brain irradiation and atezolizumab administration
por: Hotta, Takamasa, et al.
Publicado: (2021)

A Low Crizotinib Concentration in the Cerebrospinal Fluid Causes Ineffective Treatment of Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer with Carcinomatous Meningitis
por: Okimoto, Tamio, et al.
Publicado: (2018)

Disseminated Nocardiosis Initially Manifesting as Visual Field Defects
por: Okimoto, Tamio, et al.
Publicado: (2018)

Contrasting effects of cyclophosphamide on anti‐CTL‐associated protein 4 blockade therapy in two mouse tumor models
por: Iida, Yuichi, et al.
Publicado: (2017)

Pemetrexed in Previously Treated Non-small Cell Lung Cancer Patients with Poor Performance Status
por: Sun, Young JUNG, et al.
Publicado: (2011)

An 83‐year‐old patient with RET fusion‐positive non‐small cell lung cancer experiencing severe hepatic disorder due to selpercatinib administration
por: Nakashima, Kazuhisa, et al.
Publicado: (2023)

Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung
por: Jung, Minkyu, et al.
Publicado: (2013)

Multiple Mass Lesions in Pneumocystis Pneumonia
por: Kobayashi, Misato, et al.
Publicado: (2022)

Pifithrin-μ, an Inhibitor of Heat-Shock Protein 70, Can Increase the Antitumor Effects of Hyperthermia Against Human Prostate Cancer Cells
por: Sekihara, Kazumasa, et al.
Publicado: (2013)

Synchronous lung and gastric cancers successfully treated with carboplatin and pemetrexed: a case report
por: Sato, Takashi, et al.
Publicado: (2012)

Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung Cancer
por: Hong, Junshik, et al.
Publicado: (2010)

A retrospective analysis of cisplatin, pemetrexed, and bevacizumab in previously treated non-small-cell lung cancer
por: Liu, Ke-Jun, et al.
Publicado: (2015)

Efficacy of S‐1 after pemetrexed in patients with non‐small cell lung cancer: A retrospective multi‐institutional analysis
por: Takemoto, Shinnosuke, et al.
Publicado: (2021)

Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non‐small‐cell lung cancer
por: Otsubo, Kohei, et al.
Publicado: (2017)

Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer
por: Jo, Jaemin, et al.
Publicado: (2018)

Nephrotoxicity in a Patient Treated with Pemetrexed
por: Zajjari, Y., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m31d67hak3q2hls6f02eogu463